Sun Pharma Drugs Private Limited, a amalgamated private limited company, was established on 31 August 2012 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74120MH2012PTC235214. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹20.00 Cr.
Its leadership includes Sailesh Trambaklal Desai (Director), Sudhir Vrundavandas Valia (Director), Dilip Shantilal Shanghvi (Director). Past directors included Madhukar Krishnarao Ramdin. It is based at Acme Plaza, Andheri Kurla Road Andheri (East), Mumbai, Maharashtra, 400059.
U74120MH2012PTC235214
235214
31 August 2012
₹20.00 Cr
₹20.00 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Sun Pharma Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sailesh Trambaklal Desai | Director | 31 Aug 2012 | Current |
| Sudhir Vrundavandas Valia | Director | 31 Aug 2012 | Current |
| Dilip Shantilal Shanghvi | Director | 31 Aug 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Manager | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sun Pharma Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sun Pharma Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sun Pharma Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sun Pharma Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharma Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Madhukar Krishnarao Ramdin was appointed as a Manager was appointed as a Manager on 01 Sep 2012 & has been associated with this company since 13 years 3 months . was documented.
The activity Sailesh Trambaklal Desai was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 13 years 3 months . was completed.
Progress on Sudhir Vrundavandas Valia was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 13 years 3 months . was documented.
Dilip Shantilal Shanghvi was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.
Progress on Sun Pharma Drugs Private Limited was registered on 31 Aug 2012 with Roc Mumbai & aged 13 years 3 months as per MCA records. was documented.
Sun Pharmaceutical Industries plans to acquire all outstanding shares of Taro Pharmaceutical Industries for $43 per share in cash, aiming to gain complete control over its subsidiary.
Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa. Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients. .
The CIN of Sun Pharma Drugs Private Limited is U74120MH2012PTC235214.
Sun Pharma Drugs Private Limited is headquartered at Acme Plaza, Andheri Kurla Road Andheri (East), Mumbai, Maharashtra, 400059.
Sun Pharma Drugs Private Limited was incorporated on 31 August 2012.
The current directors of Sun Pharma Drugs Private Limited are
The primary industry of Sun Pharma Drugs Private Limited is Pharma.
Sun Pharma Drugs Private Limited is unlisted.
The authorized capital of Sun Pharma Drugs Private Limited is ₹20.00 Cr, and the paid-up capital is ₹20.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX